Insider · CIK 0001963878
Christine Bellon
Files at BEAM (Beam Therapeutics Inc.). First filing Nov 22, 2023, latest Apr 6, 2026.
In brief
Christine Bellon files SEC Form 4 as officer at BEAM (Beam Therapeutics Inc.). Since Nov 22, 2023, Christine Bellon has reported 0 open-market buys worth $0 and 9 open-market sells worth $1.7M, the latest filed on Apr 6, 2026.
A track record needs three past buys with six months of prices behind them; Christine Bellon has 0, so none is measured yet.
The newest scored trade: sold $146k of BEAM on Apr 1, 2026, filed Apr 6, 2026, scored 21 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $872k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BEAM: Beam Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Beam Therapeutics Inc. | $146k 5,956 shares | -5% | +67% from low-32% from high | |
| 16Weak | Beam Therapeutics Inc. | $47k 1,371 shares | -1% | +136% from low-3% from high | |
| 35Weak | Beam Therapeutics Inc. | $645k 18,629 shares | -16% | +120% from low-9% from high | |
| 9Weak | Beam Therapeutics Inc. | $34k 1,254 shares | -1% | +91% from low-19% from high | |
| 10Weak | Beam Therapeutics Inc. | $9,150 373 shares | -0% | +66% from low-29% from high | |
| 20Weak | Beam Therapeutics Inc. | $104k 5,674 shares | -5% | 0% from low-48% from high | |
| 3Weak | Beam Therapeutics Inc. | $340k 10,000 shares | -9% | - | |
| 8Weak | Beam Therapeutics Inc. | $31k 1,241 shares | -1% | - | |
| 0Weak | Beam Therapeutics Inc. | $305k 10,000 shares | -11% | +74% from low-37% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 31, 2026 | BEAM BEAM THERAPEUTICS INC. | 20,000 0.02% of outstanding | $438k | Apr 2, 2026 | $725k |
| Jan 22, 2026 | BEAM BEAM THERAPEUTICS INC. | 1,371 0.00% of outstanding | $47k | Jan 22, 2026 | $679k |
| Jan 15, 2026 | BEAM BEAM THERAPEUTICS INC. | 18,629 0.02% of outstanding | $645k | Jan 15, 2026 | $34k |
| Mar 31, 2025 | BEAM BEAM THERAPEUTICS INC. | 18,125 0.02% of outstanding | $403k | Apr 1, 2025 | $371k |
| Feb 14, 2025 | BEAM BEAM THERAPEUTICS INC. | 10,000 0.01% of outstanding | $340k | Feb 14, 2025 | $31k |
| Dec 30, 2024 | BEAM BEAM THERAPEUTICS INC. | 4,167 0.01% of outstanding | $105k | Dec 31, 2024 | $9,040 |
| Nov 20, 2023 | BEAM BEAM THERAPEUTICS INC. | 10,000 0.01% of outstanding | $150k | Nov 20, 2023 | $8,867 |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -5,956 | $24.58 | $146k | 109,711 | Apr 6, 2026 |
| Mar 31, 2026 | BEAM Beam Therapeutics Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 115,667 | Apr 2, 2026 |
| Jan 31, 2026 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 2, 2026 |
| Jan 22, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -1,371 | $34.00 | $47k | 95,667 | Jan 26, 2026 |
| Jan 15, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -2,111 | $33.62 | $71k | 113,556 | Jan 20, 2026 |
| Jan 15, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -15,959 | $34.72 | $554k | 97,597 | Jan 20, 2026 |
| Jan 15, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -559 | $35.40 | $20k | 97,038 | Jan 20, 2026 |
| Dec 31, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -1,254 | $27.10 | $34k | 115,667 | Jan 5, 2026 |
| Oct 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -373 | $24.53 | $9,150 | 116,921 | Oct 3, 2025 |
| Apr 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -5,674 | $18.35 | $104k | 117,294 | Apr 3, 2025 |
| Mar 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 122,968 | Apr 2, 2025 |
| Feb 14, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +9,492 | $7.22 | $69k | 112,460 | Feb 19, 2025 |
| Feb 14, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +508 | $7.22 | $3,668 | 112,968 | Feb 19, 2025 |
| Feb 14, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $34.00 | $340k | 102,968 | Feb 19, 2025 |
| Feb 14, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,492 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 14, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -508 | $0.00 | $0 | 10,410 | Feb 19, 2025 |
| Jan 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 3, 2025 |
| Jan 2, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -1,241 | $24.68 | $31k | 102,968 | Jan 6, 2025 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +4,182 | $7.22 | $30k | 86,584 | Nov 22, 2023 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +5,818 | $7.22 | $42k | 92,402 | Nov 22, 2023 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $30.00 | $150k | 87,402 | Nov 22, 2023 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $31.00 | $155k | 82,402 | Nov 22, 2023 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,182 | $0.00 | $0 | 9,492 | Nov 22, 2023 |
| Nov 20, 2023 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,818 | $0.00 | $0 | 10,918 | Nov 22, 2023 |
Questions about Christine Bellon
Answered from the filings on this page, as of the latest one.
Is Christine Bellon buying or selling?
In the last 12 months Christine Bellon reported 0 open-market buys worth $0 and 4 open-market sells worth $872k on SEC Form 4; the latest was sold $146k of BEAM on Apr 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Christine Bellon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Bellon has 0.
Where does Christine Bellon file Form 4?
Christine Bellon has filed Form 4 at BEAM (Beam Therapeutics Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.